Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - May 2013


3rd Serialization and Traceability for Brand Protection

09 May 2013 - 10 May 2013 - Philadelphia, PA, USA



Bookmark and Share


ExL Pharma’s 3rd Life Science Serialization and Traceability For Brand Protection is the premier event providing pharmaceutical & life science companies with comprehensive take-back-to-the-office serialization, traceability and e-pedigree strategies.

While there is a continued lack of federal guidance, it is still imperative to make the business case for your organization for brand protection purposes. If the supply chain partners are buttoned up throughout your drug’s journey to the customer, you are adding significant value to your brand by not allowing counterfeit or rogue drugs to damage your reputation.

The 2013 event will challenge the audience with new perspectives, speakers, formats and topics not often seen on the conference circuit, including:

Preparing pharma for California’s 2014/15 serialization mandate.

Learning from other industries:  How The Auto Industry Embraced and Integrated Serialization & Track & Trace

End to End Traceability doesn’t end with the wholesaler: Perspectives from pharmacies, hospitals and consumers on stage.

Top Reasons to Attend

This event prepares pharma for California's 2014 Serialization Mandate.

This event teaches pharma the business case for serialization and traceability in the most pain free and cost effective way

This event provides multiple perspectives throughout the supply chain- pharmacies, manufacturers and wholesalers.



Further information
Scientific News
Shedding Light on HIV Vaccine Design
Broadly speaking - Mathematical modelling of host-pathogen coevolution sheds light on HIV vaccine design.
Progress In Vaccination Against Vespid Venom
Researchers at the Helmholtz Zentrum München and the Technical University Munich have presented a method which facilitates a personalised procedure for wasp allergy sufferers.
FINCH Filgotinib Phase 3 Program Initiated
Galapagos NV reports the initiation of the FINCH global Phase 3 program in rheumatoid arthritis patient populations.
New Method of Cancer Immunotherapy
Stanford chemists have dicovered a new form of cancer immunotherapy using sugar presence manipulation.
Vortex Ring Freezing Applications
Accidental lab discovery could aid cell delivery and cell-free protein production.
Examining Immune Memory
Researchers investigate the 'storage/research for the future' functions of antibodies and understanding of B cells.
Expanding the Stable of Workhorse Yeasts
New genome sequences target the next generation of yeasts with improved biotechnology uses.
How Cloud Connectivity Can Combat the Reproducibility Crisis
This infographic explains the reproducibility crisis, and how cloud connectivity can help overcome this problem.
Blocking the Migration of Cancer Cells to Destroy Them
Scientists in Geneva developed an antibody able to fight off lymphomas.
Mutations Linked to Immunotherapy Resistance
Researchers uncover mutations in tumors of three patients with advanced melanoma that allowed the tumors to become resistant to the immune checkpoint inhibitor pembrolizumab (Keytruda®).
Scroll Up
Scroll Down
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!